Human medicinehttps://www.ema.europa.eu/en/homepageHuman medicineen-gbCopyright: (C) European Medicines AgencyThu, 02 May 2024 17:55:40 +0200Tue, 09 Apr 2024 12:42:00 +0200Human medicines European public assessment report (EPAR): Komboglyze, saxagliptin,metformin hydrochloride, Date of authorisation: 24/11/2011, Revision: 22, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/komboglyzeHuman medicines European public assessment report (EPAR): Komboglyze, saxagliptin,metformin hydrochloride, Date of authorisation: 24/11/2011, Revision: 22, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/komboglyzeTue, 09 Apr 2024 12:42:00 +0200Human medicineKomboglyze : EPAR - Procedural steps taken and scientific information after authorisationhttps://www.ema.europa.eu/system/files/documents/procedural-steps-after/h-2059-steps-after_en.pdfKomboglyze : EPAR - Procedural steps taken and scientific information after authorisationhttps://www.ema.europa.eu/system/files/documents/procedural-steps-after/h-2059-steps-after_en.pdfTue, 09 Apr 2024 10:42:00 +0200Human medicine